Pfizer Inc. (NYSE:PFE)
Q3 2017 Earnings Call
October 31, 2017 10:00 am ET
Executives
Charles E. Triano - Pfizer Inc.
Ian C. Read - Pfizer Inc.
Frank A. D'Amelio - Pfizer Inc.
Albert Bourla - Pfizer Inc.
Mikael Dolsten - Pfizer Inc.
John D. Young - Pfizer Inc.
Douglas M. Lankler - Pfizer Inc.
Analysts
Umer Raffat - Evercore ISI
Christopher Schott - JPMorgan Securities LLC
Andrew S. Baum - Citigroup Global Markets Ltd.
Gregg Gilbert - Deutsche Bank Securities, Inc.
David Maris - Wells Fargo Securities LLC
Jami Rubin - Goldman Sachs & Co. LLC
Seamus Fernandez - Leerink Partners LLC
Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC
David R. Risinger - Morgan Stanley & Co. LLC
Tim Anderson - Sanford C. Bernstein & Co. LLC
John T. Boris - SunTrust Robinson Humphrey, Inc.
Richard J. Purkiss - Piper Jaffray Ltd.
Steve Scala - Cowen and Co. LLC
Alex Arfaei - BMO Capital Markets (United States)
Marc Goodman - UBS Securities LLC
Olivia Brayer - Guggenheim Securities LLC
Jeffrey Holford - Jefferies LLC
Geoffrey Meacham - Barclays Capital, Inc.
Operator
Good day, everyone, and welcome to Pfizer's third quarter 2017 earnings conference call. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.
